Brief: Emcure Pharmaceuticals Says USFDA Inspection At API Manufacturing Maharashtra Facility
26/02/2025 06:23
Feb 26 (Reuters) - Emcure Pharmaceuticals Ltd EMCU.NS: USFDA INSPECTION AT API MANUFACTURING MAHARASHTRA FACILITY CO RECEIVED TWO OBSERVATIONS IN FORM 483 Source text: [ID:] Further company coverage: EMCU.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees